| Trial ID: | L6690 |
| Source ID: | NCT00373178
|
| Associated Drug: |
Rosiglitazone
|
| Title: |
Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: rosiglitazone|DRUG: metformin|DRUG: Anti-diabetic medications
|
| Outcome Measures: |
Primary: Novel cardiovascular risk factors modification, 2 years | Secondary: Lipid and glucose regulation, 2 years
|
| Sponsor/Collaborators: |
Sponsor: Aristotle University Of Thessaloniki | Collaborators: University of Athens
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-01
|
| Completion Date: |
2008-06
|
| Results First Posted: |
|
| Last Update Posted: |
2012-11-02
|
| Locations: |
AHEPA University Hospital of Thessaloniki, Thessaloniki, Greece|Aristotle University of Thessaloniki, Thessaloniki, Greece
|
| URL: |
https://clinicaltrials.gov/show/NCT00373178
|
